These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 36229358)
1. Parkinson's disease: connecting mitochondria to inflammasomes. Lawrence GMEP; Holley CL; Schroder K Trends Immunol; 2022 Nov; 43(11):877-885. PubMed ID: 36229358 [TBL] [Abstract][Full Text] [Related]
2. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072 [TBL] [Abstract][Full Text] [Related]
3. NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease. Javed H; Thangavel R; Selvakumar GP; Dubova I; Schwartz N; Ahmed ME; Zaheer S; Kempuraj D; Iyer S; Zaheer A; Khan MM Int Immunopharmacol; 2020 Jun; 83():106441. PubMed ID: 32259702 [TBL] [Abstract][Full Text] [Related]
4. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease. Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T Front Immunol; 2021; 12():719807. PubMed ID: 34691027 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease. Zhou Y; Lu M; Du RH; Qiao C; Jiang CY; Zhang KZ; Ding JH; Hu G Mol Neurodegener; 2016 Apr; 11():28. PubMed ID: 27084336 [TBL] [Abstract][Full Text] [Related]
6. HCH6-1, an antagonist of formyl peptide receptor-1, exerts anti-neuroinflammatory and neuroprotective effects in cellular and animal models of Parkinson's disease. Wang HL; Cheng YC; Yeh TH; Liu HF; Weng YH; Chen RS; Chen YC; Lu JC; Hwang TL; Wei KC; Liu YC; Wang YT; Hsu CC; Chiu TJ; Chiu CC Biochem Pharmacol; 2023 Jun; 212():115524. PubMed ID: 37001680 [TBL] [Abstract][Full Text] [Related]
8. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome. Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454 [TBL] [Abstract][Full Text] [Related]
9. Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease. Haque ME; Akther M; Jakaria M; Kim IS; Azam S; Choi DK Mov Disord; 2020 Jan; 35(1):20-33. PubMed ID: 31680318 [TBL] [Abstract][Full Text] [Related]
10. Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson's Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment. Que R; Zheng J; Chang Z; Zhang W; Li H; Xie Z; Huang Z; Wang HT; Xu J; Jin D; Yang W; Tan EK; Wang Q Front Immunol; 2021; 12():794770. PubMed ID: 34925379 [TBL] [Abstract][Full Text] [Related]
11. NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson's Disease. Han QQ; Le W Neurosci Bull; 2023 May; 39(5):832-844. PubMed ID: 36757612 [TBL] [Abstract][Full Text] [Related]
12. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease. Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861 [TBL] [Abstract][Full Text] [Related]
14. Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson's disease. Qin Y; Qiu J; Wang P; Liu J; Zhao Y; Jiang F; Lou H Brain Behav Immun; 2021 Jan; 91():324-338. PubMed ID: 33039664 [TBL] [Abstract][Full Text] [Related]
15. Ellagic Acid Protects Dopamine Neurons via Inhibition of NLRP3 Inflammasome Activation in Microglia. He XM; Zhou YZ; Sheng S; Li JJ; Wang GQ; Zhang F Oxid Med Cell Longev; 2020; 2020():2963540. PubMed ID: 33294118 [TBL] [Abstract][Full Text] [Related]
16. Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson's disease. Rajan S; Tryphena KP; Khan S; Vora L; Srivastava S; Singh SB; Khatri DK Ageing Res Rev; 2023 Jun; 87():101915. PubMed ID: 36963313 [TBL] [Abstract][Full Text] [Related]
17. Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson's disease. Grotemeyer A; Fischer JF; Koprich JB; Brotchie JM; Blum R; Volkmann J; Ip CW J Neuroinflammation; 2023 Mar; 20(1):79. PubMed ID: 36945016 [TBL] [Abstract][Full Text] [Related]
18. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease. Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303 [TBL] [Abstract][Full Text] [Related]
19. Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson's disease model. Qiu J; Chen Y; Zhuo J; Zhang L; Liu J; Wang B; Sun D; Yu S; Lou H Neuropharmacology; 2022 Apr; 207():108963. PubMed ID: 35065082 [TBL] [Abstract][Full Text] [Related]
20. Inflammasome Activation in Parkinson's Disease. Jewell S; Herath AM; Gordon R J Parkinsons Dis; 2022; 12(s1):S113-S128. PubMed ID: 35848038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]